Status:
COMPLETED
Oral Manifestation in Patients With SARS-CoV2 Infection.
Lead Sponsor:
Fayoum University
Conditions:
SARS-CoV Infection
Eligibility:
All Genders
18-60 years
Brief Summary
The oral cavity is particularly susceptible to viral infection with several viruses such as herpes simplex virus, cytomegalovirus and Zika virus because of its structures, especially salivary glands a...
Detailed Description
The SARS-Cov2 virus was identified in china at the end of 2019 and spread worldwide causing a global pandemic. Current research showed that SARS-Cov2 virus invades human cells via the receptor angiote...
Eligibility Criteria
Inclusion
- A diagnosis of SARS-CoV2 with PCR.
- Age range from 18-60 years old
Exclusion
- Pregnancy or contraceptive pills
- Lactation
- Any auto-immune disease that could affect the oral mucosa
- On any neoplastic therapy.
- Uncontrolled diabetes
Key Trial Info
Start Date :
April 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 15 2021
Estimated Enrollment :
583 Patients enrolled
Trial Details
Trial ID
NCT04821986
Start Date
April 1 2021
End Date
October 15 2021
Last Update
November 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Dentistry
Al Fayyum, Egypt, 63514